HighCape Capital — Full Portfolio

Develops therapeutics targeting altered NAD metabolism in cancer, based on IP licensed from Yale University.

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)

BoardColleen Cuffaro(Director)inMatthew Cohen(Director)in

Co-investorsCanaan PartnersConnecticut InnovationsOUP (Osage University Partners)

Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.

HealthtechNewton, US

Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)

BoardSteven Reeders(Director)Renard Charity(Director)Anthony Moshal(Director)

Co-investorsAscension VenturesMVM Life Science PartnersRobert Bosch Venture Capital

HealthtechNew Haven, US

Ilaa Agarwal(Executive Officer)Stacie Bratcher(Executive Officer)paul reiferson(Executive Officer, Director)ralph finger(Executive Officer, Director)Jennifer Barretta(Executive Officer)Mike Waters(Director)

Co-investorsConnecticut Innovations

Oncology-focused platform company whose alphalex technology enables antigen-independent targeted intracellular delivery of small molecule cancer drugs; based in New Haven, CT.

Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.

BiotechHealthtechMedical Devices

Per Hellsund(Co-founder, President & CEO)inRanjit Bindra(Scientific Co-founder & Chief Scientific Advisor)inPeter Glazer(Scientific Co-founder & Chief Medical Advisor)in

Co-investorsConnecticut Innovations

Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.

BiotechHealthtechMedical Devices

C. Randal Mills(Founder, President & CEO)in

MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.

FintechLogistics & Supply ChainSaaSBainbridge Island, US

Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)

Co-investorsIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders CapitalPathway Bioventures

Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.

BiotechHealthtechNew Haven, US

Ranjit Bindra(Director)Kingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)

BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)

Co-investorsConnecticut InnovationsPathway BioventuresIronwood Capital

Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.

BiotechDeep TechHardwareMedical Devices

Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in

Co-investorsForesite CapitalYuanBio Venture Capital

Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.

Antony Koblish(Founder)in

Co-investorsOrbiMed

Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.

Digital HealthHealthtechWellness & FitnessNew Haven, US

Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in

Co-investorsConnecticut Innovations

Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.